← Leaderboards
Charles J Frazier
University Of Alabama At Birmingham
$5,884,504
Attributed
$10,338,959
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,338,959 · 8
By mechanism
R01$6,263,868 · 4
RF1$3,004,660 · 1
R56$588,044 · 1
R21$402,875 · 1
F32$79,512 · 1
Top collaborators
- Maria B Grant6 shared
- Guillaume Fh De Lartigue4 shared
- Michael Edwin Boulton3 shared
- Jennifer Lynn Bizon1 shared
- Annette Diane De Kloet1 shared
- Eric Gerald Krause1 shared
- Barry Setlow1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Maria B Grant$24,532,308
- Michael Edwin Boulton$9,864,814
- Xiaoguang Margaret Liu$3,757,363
- Renata Jaskula-Sztul$501,522
- Gail V. W. Johnson$17,014,360
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsBrainSignal TransductionMediatingSynapsesHypothalamic StructureAreaCellsRegulationFunctional DisorderRattusPresynapticBaseAgonistInsightBehavioralChronicParaventricular NucleusResponseLeadImpairmentProgramsCell NucleusEtiology
Grant awards (24)
Brain-gut-retina axis in diabetic retinopathy$524,816
R01 · FY2025 · EY
Brain-gut-retina axis in diabetic retinopathy$532,390
R01 · FY2024 · EY
Brain-gut-retina axis in diabetic retinopathy$550,644
R01 · FY2023 · EY
Leveraging vagal oxytocin receptors to understand cardiometabolic interoception$588,044
R56 · FY2022 · AT · contact PI
Somatostatin blockade of CNS autonomic hyperactivity for treatment of diabetic retinopathy$461,792
R01 · FY2020 · EY
Somatostatin blockade of CNS autonomic hyperactivity for treatment of diabetic retinopathy$471,105
R01 · FY2019 · EY
Novel Aspects of Central Oxytocin Signaling Relevant to Mood/Anxiety Disorders$375,000
R01 · FY2019 · MH · contact PI
Decision making and basolateral amygdala dysfunction in aging$3,004,660
RF1 · FY2018 · AG
Somatostatin blockade of CNS autonomic hyperactivity for treatment of diabetic retinopathy$474,726
R01 · FY2018 · EY
Novel Aspects of Central Oxytocin Signaling Relevant to Mood/Anxiety Disorders$375,000
R01 · FY2018 · MH · contact PI
Novel Aspects of Central Oxytocin Signaling Relevant to Mood/Anxiety Disorders$375,000
R01 · FY2017 · MH · contact PI
Novel Aspects of Central Oxytocin Signaling Relevant to Mood/Anxiety Disorders$375,000
R01 · FY2016 · MH · contact PI
Novel Aspects of Central Oxytocin Signaling Relevant to Mood/Anxiety Disorders$375,000
R01 · FY2015 · MH · contact PI
CB1R independent effects of cannabinoids on synaptic physiology in the CNS.$183,125
R21 · FY2012 · DA · contact PI
CB1R independent effects of cannabinoids on synaptic physiology in the CNS.$219,750
R21 · FY2011 · DA · contact PI
Endocannabinoids and tonic GABA in the dentate gyrus$272,201
R01 · FY2009 · DA · contact PI
Endocannabinoids and tonic GABA in the dentate gyrus$272,385
R01 · FY2008 · DA · contact PI
Endocannabinoids and tonic GABA in the dentate gyrus$237,809
R01 · FY2007 · DA · contact PI
Endocannabinoids and tonic GABA in the dentate gyrus.$40,323
R01 · FY2007 · DA · contact PI
Endocannabinoids and tonic GABA in the dentate gyrus.$280,607
R01 · FY2006 · DA · contact PI
Endocannabinoids and tonic GABA in the dentate gyrus$270,070
R01 · FY2005 · DA
INACTIVATION OF DELAYED RECTIFIER POTASSIUM CHANNELS$41,996
F32 · FY2001 · NS
INACTIVATION OF DELAYED RECTIFIER POTASSIUM CHANNELS$24,758
F32 · FY2000 · NS
INACTIVATION OF DELAYED RECTIFIER POTASSIUM CHANNELS$12,758
F32 · FY2000 · NS